Archive explorer

Browse & search snapshots

Important note

Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.

For background on coverage and capture methods, see Methods & coverage.

Browse archived sites

Browse all sources →

Licensed Natural Health Products Database (LNHPD) For industry information about COVID-19, visit our COVID-19 Disinfectants, sanitizers, cleaners and soaps section. What Is It? The Licensed Natural Health Products Database contains information about natural health products that…

Request a drug through the Special Access Program On this page Who can apply How to apply How we process requests How decisions are made Mandatory reporting requirements Information for manufacturers Contact us Who can apply If you're a health or dental practitioner, you can…

Assisted human reproduction - Canada.ca

Health CanadaCaptures 237Latest capture Apr 11, 2026en

Assisted human reproduction On this page Assisted human reproduction in Canada The Assisted Human Reproduction Act Strengthening the Assisted Human Reproduction Act Consultations Transitional Compliance and Enforcement Contact us Assisted human reproduction in Canada Canadians…

Regulatory innovation for health products: Overview Overview Modernizing clinical trial regulations Enabling advanced therapeutic products Agile licensing for drugs Agile licensing for medical devices Information to Canadians - mobile strategy On this page The need for regulatory…

About the Prescription Drug List - Canada.ca

Health CanadaCaptures 231Latest capture Apr 11, 2026en

About the Prescription Drug List The List Changes to the Food and Drugs Act (section 29.1) will give the Minister of Health the power to establish a list that sets out prescription drugs. The Prescription Drug List is a list of medicinal ingredients that when found in a drug,…

Access to Drugs in Exceptional Circumstances - Canada.ca

Health CanadaCaptures 228Latest capture Apr 11, 2026en

Access to Drugs in Exceptional Circumstances The Regulatory Pathway The Access to Drugs in Exceptional Circumstances regulatory pathway enables access to drugs which have been authorized for sale in certain foreign jurisdictions, but are not available in Canada, to address urgent…

Improving the regulatory review of drugs and devices Health Canada is collaborating with our international partners on issues related to drug and medical device clinical trials, authorizations, risk assessments, and potential shortages. Learn about how we are engaging our…

Mandatory reporting requirements for hospitals Reporting requirements of serious adverse drug reactions and medical device incidents for hospitals. On this page Regulatory requirements for hospitals Which hospitals must report Why and what to report When and how to submit reports…

Product monograph brand safety updates - Canada.ca

Health CanadaCaptures 222Latest capture Apr 11, 2026und

Product monograph brand safety updates On this page March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 Non-Prescription Submissions Cleared in 2014 March 2026 Product Monograph Brand…

Page 2377 of 3977Showing 23761-23770 of 39762

Early release: coverage and features are still expanding.